X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.040
-0.270 (-6.26%)
At close: Mar 27, 2026, 4:00 PM EDT
4.000
-0.040 (-0.99%)
After-hours: Mar 27, 2026, 4:37 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $367.32 million as of March 27, 2026. Its market cap has increased by 580.28% in one year.
Market Cap
367.32M
Enterprise Value
191.60M
1-Year Change
580.28%
Ranking
Category
Stock Price
$4.04
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $367.32M, an increase of 260.92%. That is a compound annual growth rate of 20.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 367.32M | 5.02% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 371.14M |
| PureTech Health | 369.51M |
| Polaryx Therapeutics | 368.80M |
| Century Therapeutics | 363.04M |
| Monopar Therapeutics | 362.04M |
| XOMA Royalty | 359.19M |
| DiaMedica Therapeutics | 353.61M |
| Enanta Pharmaceuticals | 353.46M |